# Comprehensive physicochemical, biophysical, and in vitro characterization of lung surfactant SP-A peptidomimetics

**Authors:** David Encinas-Basurto, Priya Muralidharan, M. D. Saiful Islam, Ernest L. Vallorz, Stephen M. Black, Monica Kraft, Julie G. Ledford, Heidi M. Mansour

PMC · DOI: 10.1039/d4pm00265b · 2025-05-06

## TL;DR

This study examines two SP-A-derived peptides and their physicochemical properties, showing they are stable and biocompatible, making them potential candidates for treating lung diseases.

## Contribution

The study provides a comprehensive characterization of SP-A-derived peptides in different salt forms, revealing their structural behavior and biocompatibility.

## Key findings

- Phosphate and acetate salts of SP-A peptides show distinct solubility and log P partitioning behavior.
- SP-A 10-AA adopts an α-helical structure initially but loses it over time, while SP-A 20-AA remains disordered.
- In vitro studies confirm high cell viability and stable TEER values, indicating biocompatibility and epithelial permeability.

## Abstract

Surfactant protein-A (SP-A) is an endogenous and essential lung surfactant-specific protein that is integral to pulmonary immunity, including inhibition of asthma exacerbations. This study aims to comprehensively characterize two peptides (10-AA and 20-AA) of SP-A which confer activity similar to the full-length oligomeric SP-A protein. Spectroscopic and chromatographic analyses revealed that the phosphate (PS) and acetate (AC) salts exhibited distinct solubility and log P partitioning behavior, impacting their physicochemical properties. MD simulations and circular dichroism showed that SP-A 10-AA initially adopts an α-helical structure but loses helicity over time, while SP-A 20-AA remains disordered. Differential scanning calorimetry confirmed variations in thermal stability between salt forms and zeta potential measurements showed that PS salts had a more negative surface charge, potentially influencing membrane interactions. In vitro studies showed high cell viability (>90%) and stable TEER values at the air–liquid interface, confirming biocompatibility and potential epithelial permeability. These findings provide crucial insights into the structural and functional properties of SP-A peptides, supporting their potential as therapeutic agents for pulmonary diseases.

This study characterizes the physicochemical properties of SP-A-derived peptides in acetate and phosphate forms, evaluating their impact on lung cell viability. Findings provide insights into their stability and potential as inhalable therapeutics.

## Linked entities

- **Proteins:** SFTPA1 (surfactant protein A1)
- **Chemicals:** phosphate (PubChem CID 1061), acetate (PubChem CID 175)
- **Diseases:** asthma (MONDO:0004979), pulmonary diseases (MONDO:0005275)

## Full-text entities

- **Genes:** SFTPA1 (surfactant protein A1) [NCBI Gene 653509] {aka COLEC4, ILD1, PSP-A, PSPA, SFTP1, SFTPA1B}
- **Diseases:** pulmonary diseases (MESH:D008171), asthma (MESH:D001249)
- **Chemicals:** P (MESH:D010758), PS (MESH:D010710), AC (MESH:D000085)

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12053052/full.md

---
Source: https://tomesphere.com/paper/PMC12053052